Álvarez-Román, Maria Teresa, Ignacio Cuervo-Arango, Rafael Pérez-Santamarina, José Luís Poveda, José Antonio Romero, Amparo Santamaría, José Luís Trillo-Mata, Marina Tort, and Xavier Badia. 2019. “Determining the Value Contribution of Emicizumab (Hemlibra®) for the Prophylaxis of Haemophilia A With Inhibitors in Spain by Multi-Criteria Decision Analysis”. Global and Regional Health Technology Assessment 6 (1). https://doi.org/10.33393/grhta.2019.452.